Sign in

CIK 0001042418

  • Non-accelerated filer
  • Smaller reporting company

Inhibitor Therapeutics, Inc.

Sign in to watch
Ticker
INTI
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
541641133
Phone
+1 813-766-2462
Business address
4830 W. KENNEDY BLVD., SUITE 600, TAMPA, FL, 33609
Former names
HedgePath Pharmaceuticals, Inc., COMMONWEALTH BIOTECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-12-22 Hasara Garrison J. CFO and Treasurer Grant or award · Common Stock Option +125,000 125,000
2020-09-17 Hasara Garrison J. CFO and Treasurer Grant or award · Common Stock Option +100,000 100,000
2019-12-02 Hasara Garrison J. CFO and Treasurer Purchase +13,500 $0.07 $945 3,972,544
2018-08-30 Hasara Garrison J. CFO and Treasurer Sale −100,000 $0.27 $27K 3,959,044
2018-03-13 Hasara Garrison J. CFO and Treasurer Grant or award · Common Stock Option +260,000 260,000
2017-03-08 Hasara Garrison J. CFO and Treasurer Exercise or conversion +3,500,000 3,500,000
2017-03-08 Hasara Garrison J. CFO and Treasurer Shares withheld for taxes −1,470,478 $0.34 $500K 2,029,522
2017-03-08 Hasara Garrison J. CFO and Treasurer Exercise or conversion +3,500,000 5,529,522
2017-03-08 Hasara Garrison J. CFO and Treasurer Shares withheld for taxes −1,470,478 $0.34 $500K 4,059,044
2017-03-08 Hasara Garrison J. CFO and Treasurer Exercise or conversion · Restricted Stock Units −3,500,000 0
2017-03-08 Hasara Garrison J. CFO and Treasurer Exercise or conversion · Restricted Stock Units −3,500,000 0

Page 1 of 1 · 11 trades